New whole-genome test uncovers hidden genetic risk beyond traditional screening, empowering earlier and more precise care for millions of men. MENLO PARK, Calif., Nov. 20, 2025 /PRNewswire/ -- MyOme, ...
Evanston, Ill.-based Northshore University HealthSystem’s center for personalized medicine rolled out a new test to assess patients’ risk of developing prostate cancer. NorthShore developed the test, ...
Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.
A family history of prostate cancer has long been one of the few universally accepted risk factors for the disease. New findings now provide evidence that risk stratification based on family history ...
The recommendation by a committee advising the U.K. government that screening for prostate cancer should not be made available to the vast majority of men could benefit companies such as Antegenes OÜ.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback